VIRTUAL STL Genome Editing Symposium: “STL Genome Editing 2021…Virtually A New Beginning”

January 21, 2021
8:00 am - 12:00 pm
Zoom conference (Virtual)

“STL Genome Editing 2021…Virtually A New Beginning”

Organized by the Genome Engineering & iPSC Center (GEiC)

January 21-22, 2021

Register today!

For inquiries contact Xiaoxia Cui.

Presentations in genome editing on cells, animals, plants, & therapeutics by:

January 21, 2021

  • Keynote speaker: Charlie Gersbach, Ph.D., Rooney Family Associate Professor of Biomedical Engineering, Duke University
  • Ibrahim Kurt, Ph. D. Candidate, Harvard University
  • Traver Hart, Assistant Professor, Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center
  • Tim Peterson, Assistant Professor of Medicine, Washington University in St. Louis
  • Shengdar Tsai, Assistant Member of the Department of Hematology, St. Jude Children’s Research Hospital
  • John Doench, Director R&D, Institute Scientist, Broad Institute of MIT and Harvard University
  • Andrew Anzalone, Head of the Prime Editing Platform at Prime Medicine, Inc.
  • Panel Discussion“Off targeting using nucleases, base editors, prime editors, and in screens”

January 22, 2021

  • Alejandro Chavez, Assistant Professor of Pathology & Cell Biology, Columbia University
  • Dongsheng Duan, Margaret Proctor Mulligan Professor in Medical Research, School of Medicine, University of Missouri, Columbia
  • Aron Geurts, Associate Professor, Department of Physiology, Medical College of Wisconsin
  • Xiaoxia Cui, Director of the Genome Engineering & iPSC Center, Washington University in St. Louis
  • Andrew Yoo, Associate Professor of Developmental Biology, Washington University in St. Louis
  • Martin Kampmann, Associate Professor, Institute for Neurodegenerative Diseases, UCSF Weill Institute for Neurosciences, University of California, San Francisco
  • Luke Gilbert, Assistant Professor, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco
  • Michael Kosicki, Postdoctoral Fellow, Lawrence Berkeley National Laboratory
  • Panel Discussion“On target large deletion, repression as KO alternative, off-targeting potential, continue first days”